BioWorld MedTech

Nov. 15, 2012

The MDD Interview: Chronic disease management cited as key market for VitalSims

Chris Duncan is CEO and a director of Vital Simulations (VitalSims; Edina, Minnesota), a company that develops and distributes web and iPad-based interactive simulation titles using virtual scenarios to improve learning outcomes. Read More

Guided Therapeutics submits amended PMA for LuViva

Regional innovation review: Diverse range of medical device companies dot Atlanta's landscape

Washington roundup: Nexon: Failure 'not an option' for medical device tax repeal

Agreements/contracts: CPAC set to deliver DWA proton therapy system

Financings roundup: U.S. Bank closes two credit facilities for Trinity Health

Report from Europe: Stryker Ireland cancels plan to eliminate 142 jobs in 2013

Patent watch: T2 Biosystems expands IP with two new U.S. patents

New ventures: RVM forms new division of vascular access centers

Mindray initiates voluntary recall for anesthesia system

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Dec. 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of brain with electrical activity background

ABS-1230 controls seizures in KCNT1-driven severe epilepsy

BioWorld Science

Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...